Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

INCIVEK 375 MG

TELAPREVIR : 375 MG · DIN 02371553 · VERTEX PHARMACEUTICALS (CANADA) INCORPORATED

Health Canada status: CANCELLED POST MARKET

What is INCIVEK?

INCIVEK 375 MG contains TELAPREVIR : 375 MG. It is listed in the Health Canada Drug Product Database under DIN 02371553, held by VERTEX PHARMACEUTICALS (CANADA) INCORPORATED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 21-Apr-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02371553
Brand nameINCIVEK
Generic / active ingredientTELAPREVIR : 375 MG
ManufacturerVERTEX PHARMACEUTICALS (CANADA) INCORPORATED
Strength375 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeJ05AP02 TELAPREVIR
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date21-Apr-2015

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02371553. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.